UPLC-Q-TOF/HSMS/MSE-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one

Chemico-Biological Interactions

Volumn 201, Issue 1-3, 2013, Pages 31-38

  Zhao, Ying Yong ^a   Zhang, Li ^c   Long, Feng Ya ^a   Cheng, Xian Long ^b   Bai, Xu ^d   Wei, Feng ^b   Lin, Rui Chao ^b  

^a NORTHWEST UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Xi'an No 4 Hospital   (China)

^d Waters Technologies Shanghai Ltd   (China)

Author keywords

Chronic renal failure; Ergosta 4,6,8(14),22 tetraen 3 one; Metabonomics; MSE; Polyporus umbellatus; Ultra performance liquid chromatography

Indexed keywords

ADENINE; BILE ACID; ERGONE; PHOSPHOLIPID; STEROID; UNCLASSIFIED DRUG;

ACCURACY; ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG MECHANISM; FECES; HISTOPATHOLOGY; METABOLITE; METABONOMICS; MOLECULAR BIOLOGY; NONHUMAN; PHOSPHOLIPID METABOLISM; RAT; RENAL PROTECTION; SEPARATION TECHNIQUE; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADENINE; ANIMALS; CHOLESTENONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISCRIMINANT ANALYSIS; FECES; HISTOCYTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; MASS SPECTROMETRY; METABOLOMICS; RATS;

EID: 84873684641     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.12.002     Document Type: Article

References (42)

1. A.J. Collins, B. Kasiske, C. Herzog, B. Chavers, R. Foley, D. Gilbertson, R. Grimm, J. Liu, T. Louis, W. Manning, A. Matas, M. McBean, A. Murray, W. St Peter, J. Xue, Q. Fan, H. Guo, S. Li, S. Li, T. Roberts, J. Snyder, C. Solid, C. Wang, E. Weinhandl, C. Arko, S.C. Chen, F. Dalleska, F. Daniels, S. Dunning, J. Ebben, E. Frazier, R. Johnson, D. Sheets, B. Forrest, D. Berrini, E. Constantini, S. Everson, P. Frederick, P. Eggers, L. Agodoa, United States Renal Data System. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States, Am. J. Kidney Dis. 45 (2005) A5-A7.
2. A. Schieppati, and G. Remuzzi Chronic renal diseases as a public health problem: epidemiology, social, and economic implications Kidney Int. 68 2005 S7 S10
3. P. Zimmet, A. Kgmm, and J. Shaw Global and societal implications of the diabetic epidemic Nature 414 2001 782 787
4. Y.M. Lao, J.G. Jiang, and L. Yan Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine Brit. J. Pharmacol. 157 2009 1128 1141
5. G. Theodoridis, H.G. Gika, I.D. Wilson, LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics, TrAC Trends Anal. Chem. 27 (2008) 251-60.
6. Y.Y. Zhao, X.L. Cheng, F. Wei, X.Y. Xiao, W.J. Sun, Y.M. Zhang, and R.C. Lin Serum metabonomics study of adenine-induced chronic renal failure rat by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry Biomarkers 17 2012 48 55
7. Y.Y. Zhao, J. Liu, X.L. Cheng, X. Bai, and R.C. Lin Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS Clin. Chim. Acta 413 2012 642 649
8. E data collection technique Biomarkers 17 2012 721 729
9. D. Bensky, and A. Gamble Chinese Herbal Medicine Materia Medica, Revised Edition 1993 Eastland Press Seattle
10. Y.Y. Zhao, Y. Zhao, Y.M. Zhang, R.C. Lin, and W.J. Sun Qualitative and quantitative analysis of the diuretic component ergone in Polyporus umbellatus by HPLC with fluorescence detection and HPLC-APCI-MS/MS Pharmazie 64 2009 366 370
11. Y.Y. Zhao, X.L. Cheng, Y.M. Zhang, Y. Zhao, R.C. Lin, W.J. Sun, Simultaneous determination of eight major steroids from Polyporus umbellatus by high-performance liquid chromatography coupled with mass spectrometry detections, Biomed. Chromatogr. 24 (2010) 222-230.
12. Y.Y. Zhao, L.B. Yang, M.M. Wang, L.L. Wang, X.L. Cheng, Y.M. Zhang, Y. Zhao, R.C. Lin, and W.J. Sun 1β-Hydroxylfriedelin, a new natural pentacylic triterpene from the sclerotia of Polyporus umbellatus J. Chem. Res. 11 2009 699 701
13. W.Y. Lee, Y. Park, J.K. Ahn, S.Y. Park, and H.J. Lee Cytotoxic activity of ergosta-4,6,8(14),22-tetraen-3-one from the sclerotia of Polyporus umbellatus Bull. Korean Chem. Soc. 26 2005 1464 1466
14. D. Yuan, J. Mori, K.I. Komatsu, T. Makino, and Y. Kano An anti-aldosteronic diuretic component (drain dampness) in Polyporus sclerotium Biol. Pharm. Bull. 27 2004 867 870
15. H. Fujimoto, E. Nakamura, E. Okuyama, and M. Ishibashi Six immunosuppressive features from an ascomycete, Zopfiella longicaudata, found in a screening study monitored by immunomodulatory activity Chem. Pharm. Bull. 52 2004 1005 1008
16. Y.Y. Zhao, R.M. Xie, X. Chao, Y.M. Zhang, R.C. Lin, and W.J. Sun Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus J. Ethnopharmacol. 126 2009 184 187
17. Y.Y. Zhao, L. Zhang, J.R. Mao, X.H. Cheng, R.C. Lin, Y.M. Zhang, and W.J. Sun Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats J. Pharm. Pharmacol. 63 2011 1581 1586
18. Y.Y. Zhao, X. Chao, Y.M. Zhang, R.C. Lin, and W.J. Sun Cytotoxic steroids from Polyporus umbellatus Planta Med. 76 2010 1755 1758
19. Y.Y. Zhao, X. Shen, X. Chao, C.C. Ho, X.L. Cheng, Y.M. Zhang, R.C. Lin, K.J. Du, W.J. Luo, J.Y. Chen, and W.J. Sun Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells BBA-Gen. Subjects 2010 1810 384 390
20. Y.Y. Zhao, X.Y. Qin, X.L. Chen, X.Y. Liu, R.C. Lin, Y.M. Zhang, X.Y. Li, X.L. Sun, and W.J. Sun Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one Anal. Chim. Acta 675 2010 199 206
21. Y.Y. Zhao, X.L. Cheng, Y. Zhang, X. Chao, Y. Zhao, R.C. Lin, W.J. Sun, A fast and sensitive HPLC-MS/MS analysis and preliminary pharmacokinetic characterization of ergone in rats. J. Chromatogr. B 878 (2010) 29-33.
22. Y.Y. Zhao, X.Y. Qin, Y. Zhang, R.C. Lin, W.J. Sun, and X.Y. Li Quantitative HPLC method and pharmacokinetic studies of ergosta-4,6,8(14),22- tetraen-3-one, a natural product with diuretic activity from Polyporus umbellatus Biomed. Chromatogr. 24 2010 1120 1124
23. E.P. Rhee, A. Souza, L. Farrell, M.R. Pollak, G.D. Lewis, D.J. Steele, R. Thadhani, C.B. Clish, A. Greka, and R.E. Gerszten Metabolite profiling identifies markers of uremia J. Am. Soc. Nephrol. 21 2010 1041 1051
24. L.W. Jia, J. Chen, P.Y. Yin, X. Lu, and G.W. Xu Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry Metabolomics 4 2008 183 189
25. K. Kikuchi, Y. Itoh, R. Tateoka, A. Ezawa, K. Murakami, and T. Niwa Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry J. Chromatogr. B 878 2010 1662 1668
26. K. Kikuchi, Y. Itoh, R. Tateoka, A. Ezawa, K. Murakami, and T. Niwa Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry J. Chromatogr. B 878 2010 2997 3002
27. Y.Y. Zhao, X.L. Cheng, F. Wei, X. Bai, and R.C. Lin Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomics study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm Clin. Chim. Acta 413 2012 1438 1445
28. E data collection technique Process Biochem. 47 2012 1980 1987
29. G. Wolf Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway Kidney Int. 70 2006 1914 1919
30. H.T. Yu Progression of chronic renal failure Arch. Intern. Med. 163 2003 1417 1429
31. M. Nangaku Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure Intern. Med. 43 2004 9 17
32. G.S. Kuncio, E.G. Neilson, and T. Haverty Mechanisms of tubulointerstitial fibrosis Kidney Int. 39 1991 550 556
33. R.C. Harris, and E.G. Neilson Toward a unified theory of renal progression Annu. Rev. Med. 57 2006 365 380
34. S. Perwaiz, B. Tuchweber, D. Mignault, T. Gilat, and I.M. Yousef Determination of bile acids in biological fluids by liquid chromatography- electrospray tandem mass spectrometry J. Lipid Res. 42 2001 114 119
35. B.K. Lopansri, N.M. Anstey, G.J. Stoddard, E.D. Mwaikambo, C.S. Boutlis, E. Tjitra, H. Maniboey, M.R. Hobbs, M.C. Levesque, J.B. Weinberg, and D.L. Granger Complications pathophysiology of neurological malaria and implications for elevated plasma phenylalanine in severe Infect. Immun. 74 2006 3355 3359
36. N. Matoba, M. Une, and T. Hoshita Identification of unconjugated bile acids in human bile J. Lipid Res. 27 1986 1154 1162
37. Z.R. Vlahcevic, W.M. Pandak, R.T. Stravitz, Regulation of bile acid biosynthesis, Gastroenterol. Clin. North Am. 28 (1999) 1-25.
38. N.B. Javitt Bile acid synthesis from cholesterol: regulatory and auxiliary pathways FASEB J. 8 1994 1308 1311
39. A.F. Hofmann, The enterohepatic circulation of bile acids in man, Clin. Gastroenterol. 6 (1977) 3-24.
40. J.P. Hamilton, G. Xie, J.P. Raufman, S. Hogan, T.L. Griffin, C.A. Packard, D.A. Chatfield, L.R. Hagey, J.H. Steinbach, and A.F. Hofmann Human cecal bile acids: concentration and spectrum Am. J. Physiol. Gastrointest. Liver Physiol. 293 2007 G256 G263
41. R. Raedsch, A. Stiehl, U. Gundert-Remy, S. Walker, A. Sieg, P. Czygan, and B. Kommerell Hepatic secretion of bilirubin Digestion 26 1983 80 88
42. V. Lorenzo-Zuniga, R. Bartoli, R. Planas, A.F. Hofmann, B. Vinado, L.R. Hagey, J.M. Hernandez, J. Mane, M.A. Alvarez, V. Ausina, and M.A. Gassull Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats Hepatology 37 2003 551 557